Poster presentations

72 / 8 – A spatial interactomics approach reveals interplay between the tumor microenvironment and T cell activation
Session PO.IM01.01 – Biomarkers, Immune Monitoring, and Immune Assays
Date and Time: Sunday Apr 7, 2024 1:30 PM – 5:00 PM
Poster 8 in Section 3
Read abstract #72

1525 / 12 – Integration of high-plex tumor-Immune phenotyping and checkpoint interactions for deeper spatial characterization of human cancer tissues
Session PO.TB11.07 – Immune Cells in the Tumor Microenvironment 1
Date and Time: Monday Apr 8, 2024 9:00 AM – 12:30 PM
Poster 12 in Section 9
Read abstract #1525

2744 / 2 – Exploring the role of the MSLN/MUC16 interaction in cancer progression via the in situ proximity ligation technique
Session PO.TB04.02 – Biomarkers and Expression Differences in Metastatic Progression
Date and Time: Monday Apr 8, 2024 1:30 PM – 5:00 PM
Poster 2 in Section 7
Read abstract #2744

5188 / 29 – Defining PD-1/PD-L1 receptor-ligand interactions in the head and neck cancer tumor microenvironment identifies unique ‘immune cell rivers’ of cellular interactions
Session PO.CL01.11 – Predictive Biomarkers 4
Date and Time: Tuesday Apr 9, 2024 9:00 AM – 12:30 PM
Poster 29 in Section 45
Read abstract #5188

5354 / 5 – High-resolution analysis of immune checkpoint activation utilizing a combined PD1/PD-L1 in situ proximity ligation assay (isPLA) and multiplex immunofluorescence (mIF) imaging approach
Session PO.CL01.11 – Predictive Biomarkers 4
Date and Time: Tuesday Apr 9, 2024 1:30 PM – 5:00 PM
Poster 5 in Section 5
Read abstract #5354

7517 / 5 – Integrating in situ proximity ligation assay for PD1-PDL1 interaction with multiplexed immunofluorescence imaging
Session PO.CL06.10 – Immune Checkpoint Inhibitor Therapy
Date and Time: Wednesday Apr 10, 2024 9:00 AM – 12:30 PM
Poster 5 in Section 42
Read abstract #7517